MedPath

Shanghai First Maternity and Infant Hospital

🇨🇳China
Ownership
-
Established
1947-01-01
Employees
-
Market Cap
-
Website
http://www.51mch.com/en.aspx

Sevoflurane for Treatment-Resistant Depression

Not Applicable
Conditions
Depressive Disorder, Major
Depressive Disorder, Treatment-Resistant
Interventions
Drug: Placebo
Drug: Sevoflurane
First Posted Date
2021-08-17
Last Posted Date
2021-08-17
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
15
Registration Number
NCT05008939
Locations
🇨🇳

Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, Shanghai, China

Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol

Not Applicable
Completed
Conditions
IVF
Interventions
Procedure: Gonadotrophin releasing hormone antagonist protocol
Procedure: Progestin-primed ovarian stimulation protocol
First Posted Date
2021-08-04
Last Posted Date
2024-02-28
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
240
Registration Number
NCT04989348
Locations
🇨🇳

Shanghai first Maternity and Infant health hospital, Tong Ji University, Shanghai, China

A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome

Phase 4
Conditions
Antiphospholipid Syndrome
Recurrent Miscarriage
Interventions
First Posted Date
2020-11-10
Last Posted Date
2020-11-10
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
384
Registration Number
NCT04624269
Locations
🇨🇳

shanghai First Maternity and Infant Hospital, Tongji University School of Medicin, Shanghai, China

Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery

Early Phase 1
Conditions
Adenomyosis of Uterus
Interventions
Drug: Aspirin/placebo
First Posted Date
2020-09-02
Last Posted Date
2020-09-02
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
550
Registration Number
NCT04535804

Research of Diagnostic Value for BMJ Infants

Conditions
Jaundice, Neonatal
Interventions
Diagnostic Test: Neonatal hyperbilirubinemia
First Posted Date
2020-08-26
Last Posted Date
2020-08-26
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
300
Registration Number
NCT04527536

Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial Carcinoma

Not Applicable
Conditions
Endometrial Cancer
Interventions
First Posted Date
2020-06-23
Last Posted Date
2020-06-23
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
20
Registration Number
NCT04444193

Assessment of Ovarian Reserve After Laparoscopic Cystectomy Versus Aspiration/Electrocoagulation in the Treatment of Ovarian Endometrioma

Not Applicable
Conditions
Ovarian Endometrioma
Ovarian Reserve
Interventions
Procedure: laparoscopic cystectomy
Procedure: laparoscopic aspiration/electrocoagulation
First Posted Date
2019-11-05
Last Posted Date
2021-06-11
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
60
Registration Number
NCT04151173
Locations
🇨🇳

Shanghai First Maternity and Infant Hospital, Shanghai, Shanghai, China

Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer

Early Phase 1
Conditions
Endometrial Cancer Stage I
Interventions
Drug: PD-1 inhibitor combined progesterone
Drug: progesterone
First Posted Date
2019-08-06
Last Posted Date
2019-08-06
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
60
Registration Number
NCT04046185

The Use of High-energy Digestible Food in Women Undergoing Caesarean Section

Not Applicable
Conditions
Caesarean Section
Interventions
Dietary Supplement: glucose injection G1
Dietary Supplement: high-energy digestible food E2
Dietary Supplement: glucose injection G2
Dietary Supplement: high-energy digestible food E1
Dietary Supplement: normal saline N2
Dietary Supplement: normal saline N1
First Posted Date
2018-11-20
Last Posted Date
2018-11-20
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
140
Registration Number
NCT03747016
Locations
🇨🇳

Shanghai First Maternity and Infant Hospital, affiliated to Tongji University, Shanghai, Shanghai, China

Neutrophil Extracellular Traps Mediate Antiphospholipid Antibody-induced Pregnancy Loss

Conditions
Neutrophil Extracellular Traps; Antiphospholipid Antibody-induced Pregnancy Loss
First Posted Date
2018-11-08
Last Posted Date
2018-11-08
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Target Recruit Count
100
Registration Number
NCT03735108
Locations
🇨🇳

Shanghai First Maternity and Infant Hospital, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath